Risk Minimisation Material: Sprayvato (Esketamine) Nasal Spray – Healthcare Professional Guide

This guide informs healthcare professionals about identified risks that may occur following treatment: transient dissociative states, sedation, increased blood pressure and drug abuse. It explains how to minimise and manage these risks.

SPS commentary:

A “Readiness to Leave” checklist (to ensure patients are safe to be discharged following administration), and a patient guide have been produced in conjunction.


electronic Medicines compendium

Resource links:

Readiness to Leave checklist

Patient Guide